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Mycosis fungoides with xanthomatizationCase report
A 37-year-old man presented with a 10-year history of brownish
patch on his right upper arm with yellowish discoloration devel-
oping gradually in the past 2 years (Figure 1A). In addition, another
two brownish patches on his left ﬂank and right thigh were ﬁrst
observed 6 and 4 years ago, respectively. Physical examination
revealed three discolored patches without deﬁnite scaling and
ulceration over the right upper arm (6 4 cm, brownish to
yellowish), the left ﬂank (5 4 cm, brownish), and the right thigh
(4 3 cm, brownish), respectively. Laboratory tests showed an
elevated fasting cholesterol of 5.73 mmol/L (3–5), a fasting triglyc-
eride of 2 mmol/L (0.6–1.2), and a low-density lipoprotein of 4.3
mmol/L (2–3), whereas the high-density lipoprotein was normal
at 1.1 mmol/L (0.9–2). A follow-up examination was performed 1
year later, and it revealed a fasting cholesterol of 5.43 mmol/L (3–
5), a fasting triglyceride of 1.94 mmol/L (0.6–1.2), a low-density
lipoprotein of 3.8 mmol/L (2–3), and a high-density lipoprotein of
1.1 mmol/L (0.9–2). The skin biopsy from the brownish patch on
the ﬂank revealed the typical dermatopathology of mycosis fun-
goides (MF) at the patch stage, and the biopsy from the brown-
yellowish patch over the upper arm showed epidermotropism,
and below the lymphocytic inﬁltration were many foamy cells in
close proximity (Figure 2A–D), which stained positive for CD68
(Figure 3C) but negative for CD45RO. Most epidermotropic atypical
lymphocytes were stained positive for CD4 and only a few positive
for CD8 (Figure 3A,B). The patient received regular narrow band
UVB (NBUVB) phototherapy for 1 year (dose¼ 0.5–1.6 J/cm2, cumu-
lative dose¼ 172.75 J) and the lesion has diminished signiﬁcantly
(Figure 1B).Figure 1 (A) The brownish patch with yellowish discoloration over the right upper arm show
treatment for 1 year was noted in the same lesion.
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Cutaneous T cell lymphoma (CTCL) is composed of a heterogeneous
group of malignant lymphomas. MF is the most common variant of
CTCL, and the typical clinical manifestation of MF is erythematous
macules and papules at the early stage, often resembling eczema
or psoriasis.
We should differentiate this case clinically from granulomatous
slack skin (GSS) because GSSmay also involve the area of axilla. GSS
is clinically manifested as red to violet, atrophic and well-
circumscribed plaques with ﬁne scales over intertriginous areas,
such as axilla and inguinal areas. The dermatopathological features
of GSS are small- tomedium-sized lymphocytes in the dermis, non-
caseating granulomas, histiocytes and multinucleated cells con-
taining very large numbers of nuclei throughout the dermis to
the subcutaneous tissue. Thus, our case is easily distinguished
from GSS by pathological ﬁndings.
To date, xanthomatous change in MF has been rarely reported.
Xanthomatous change may occur in tumor stage MF as a result of
dystrophic change.1 McCadden et al1 has proposed that cellular
lipids were released from the neoplastic cells after local tissue
hypermetabolism or damage following therapy, and then the lipids
were processed and engulfed by macrophages. In another report,
Ross et al2have reported a case of MF with xanthomatized atypical
T lymphocytes in a subject with hyperlipidemia. It was suggested
that the malignant T cell might play a direct role in the processing
of lipoprotein and the xanthomatization. In our case, although
there was signiﬁcant improvement of the lesions after a course of
1-year NBUVB phototherapy, the blood lipid levels were slightly
higher than the normal ranges both before and after the course ofed no deﬁnite scaling and ulceration. (B) A signiﬁcantly regressed macule after NBUVB
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Figure 2 (A) Typical features of mycosis fungoides with epidermotropism (H&E, 40). (B) Scattered foamy cells were noted below the lymphocytic inﬁltration (H&E, 200).
(C) Close-up view of the focal epidermotropism (H&E, 400). (D) Abundant lymphocytes and foamy cells were noted in the dermis (H&E, 400).
Figure 3 (A) Most epidermotropic atypical lymphocytes were positive for CD4. (CD4, original magniﬁcation 400). (B) Only a few epidermotropic atypical lymphocytes were posi-
tive for CD8. (CD8, original magniﬁcation 400). (C) CD68 stained most histiocytes in the dermis. (CD68, original magniﬁcation 400).
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thomatization might not be related to the patient’s hyperlipidemia.
Moreover, these xanthomatized cells stained positive for CD68 and
negative for CD45RO, suggesting that these cells are macrophages
rather than T cells. Taken together, this ﬁnding suggests that the
xanthomatization may be the result of local dystrophic change.
Xanthomatization in both inﬂammatory and neoplastic cuta-
neous diseases has been previously reported.3 In CTCL, xanthoma-
tization has been shown to occur as a result of dystrophic change or
to be secondary to systemic hyperlipidemia. However, xanthomati-
zation occurred exclusively at the tumor stage of CTCL in all the
previous reports.4
The therapy of early stage MF has various modalities, including
topical potent steroids, topical nitrogen mustard, topical carmus,
psoralen with ultraviolet A (PUVA), NBUVB, and electron beam
radiotherapy.5 The mechanism of action of NBUVB for MF still
remains unclear, but the possible explanation includes inhibition
of the antigen-presenting function of Langerhans cells, induction
of the apoptosis and reduction of the proliferation of clonal T cells.
Here we report for the ﬁrst time that xanthomatization was
observed in the patch stage MF, but the exact pathomechanism of
the foamy histiocytes at the patch stage of MF still remains elusive
and awaits further study.
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